Home - Products - Others - Other Targets - 5-Amino-4-imidazolecarboxamide

5-Amino-4-imidazolecarboxamide

CAS No. 21299-72-9

5-Amino-4-imidazolecarboxamide( —— )

Catalog No. M13390 CAS No. 21299-72-9

An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 45 In Stock
25MG 61 In Stock
50MG 98 In Stock
100MG 129 In Stock
200MG 181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-Amino-4-imidazolecarboxamide
  • Note
    Research use only, not for human use.
  • Brief Description
    An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.
  • Description
    An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21299-72-9
  • Formula Weight
    126.12
  • Molecular Formula
    C4H6N4O
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    Cl.NC(=O)C1=C(N)N=CN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Velavan A, et al. Org Biomol Chem. 2012 Aug 21;10(31):6420-3
molnova catalog
related products
  • 3-O-Methylviolanone

    3'-O-methylviolanone has anti-inflammatory activity.

  • CRF, bovine TFA (923...

    CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. CRF shows pEC50s of 11.16, 8.53 and 8.70 for human CRF1, human CRF2 and rat CRF2α.

  • FL118

    FL118 is a novel survivin inhibitor that inhibits cancer stem cell-like properties.FL118 is a novel camptothecin analog with anticancer activity that inhibits epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway, thereby inhibiting migration and invasion of human breast cancer cells.